foxo4-dri senolytic 2024 study UK | Peptide Research Peptide Inhibitors Targeting FOXO4-p53 Interactions

There are theoretical concerns around hormonesensitive conditions, cancer biology, or immune effects, so Better Med Spa screens carefully, avoids use in highrisk populations, and uses conservative, cyclical dosing with medical monitoring

This overgrowth leads to fermentation, gas production, inflammation, and symptoms that closely mirror IBS

However, their ability to dramatically improve metabolic health markers (insulin sensitivity, visceral fat, inflammation) addresses major drivers of biological aging

Other signs may include numbness, weakness, fatigue, and difficulty walking

Allergic reactions may require longer healing time and potentially medical treatment

However, your specific schedule will depend on your individual response to treatment and any symptoms you may experience